AstroNova, Inc. (NASDAQ:ALOT – Get Free Report) saw a large drop in short interest during the month of December. As of December 31st, there was short interest totalling 8,500 shares, a drop of 66.1% from the December 15th total of 25,100 shares. Based on an average daily volume of 18,000 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.1% of the shares of the company are sold short.
Wall Street Analyst Weigh In
Separately, StockNews.com downgraded AstroNova from a “strong-buy” rating to a “buy” rating in a research note on Thursday, December 12th.
Check Out Our Latest Research Report on AstroNova
Hedge Funds Weigh In On AstroNova
AstroNova Price Performance
ALOT traded up $0.03 during midday trading on Monday, reaching $11.78. 476 shares of the company’s stock were exchanged, compared to its average volume of 9,140. The business’s 50-day moving average price is $13.85 and its 200 day moving average price is $14.16. The stock has a market capitalization of $88.69 million, a PE ratio of 14.02 and a beta of 0.67. AstroNova has a 1-year low of $11.53 and a 1-year high of $18.83. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.87 and a quick ratio of 0.73.
AstroNova (NASDAQ:ALOT – Get Free Report) last announced its earnings results on Thursday, December 12th. The business services provider reported $0.06 EPS for the quarter. AstroNova had a return on equity of 7.77% and a net margin of 4.20%.
About AstroNova
AstroNova, Inc designs, develops, manufactures, and distributes specialty printers, and data acquisition and analysis systems in the United States, Europe, Asia, Canada, Central and South America, and internationally. The company operates in two segments, Product Identification (PI) and Test & Measurement (T&M).
Featured Stories
- Five stocks we like better than AstroNova
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Delta Can Fly to New Highs in 2025; Here’s Why
- Top Biotech Stocks: Exploring Innovation Opportunities
- Snowflake Stock: Bullish Upgrades Demand Investors’ Attention
Receive News & Ratings for AstroNova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstroNova and related companies with MarketBeat.com's FREE daily email newsletter.